UMerus uthe ngoLwesine ukuthi inhlanganisela ye-petosemtamab yayo yezidakamizwa yokuhlola nge-inhibitor ukhiye igcinile i-79% yeziguli ezisanda kuthola unyaka owodwa, ngokubheka okusha kwecala lomtholampilo.
Idatha yokusinda iyi-Snapshot kuphela. UMerus, i-Dutch Biotech, kuzodingeka aqedele isifundo esikhudlwana, angahleliwe ukuze abonakale kahle ukuthi umuthi wawo ungangezelela izimpilo zawo ezineziguli ezinomdlavuza wekhanda kanye nentamo ngale ndlela yokwelashwa yamanje. Kepha okwamanje, imiphumela yokusinda kokuqala iyakhuthaza futhi ifaniswe nokulindelwe kwabatshalizimali.
Isikhathi Seposi: 2025 - 05 - 26 5:45:45:05
